Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda

The article addresses the use of intravenous artesunate in treating severe malaria in Uganda, where artemisinin-resistant strains are present. Artesunate is an effective antimalarial drug administered directly into the vein. The study was published in the New England Journal of Medicine in June 2026. The research focuses on the efficacy of this treatment in patients with severe malaria in an area with artemisinin-resistant parasite strains. The intravenous form of the drug allows for faster onset of action compared to other administration routes. The study results contribute to understanding treatment options for malaria in regions with antimalarial resistance.